Stay updated on ENABLE Study: Lanadelumab in HAE Clinical Trial
Sign up to get notified when there's something new on the ENABLE Study: Lanadelumab in HAE Clinical Trial page.

Latest updates to the ENABLE Study: Lanadelumab in HAE Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedA new revision (v3.6.0) was added to the study record. The study is now listed as no longer looking for participants, replacing the previous revision (v3.5.5).SummaryDifference0.4%

- Check16 days agoChange DetectedThe record history gains a new revision entry labeled v3.5.5, replacing the previous v3.5.4. This signals a software update to the history display rather than a change to the study data.SummaryDifference0.1%

- Check37 days agoChange DetectedA new site revision (v3.5.4) is added to the record history, replacing the previous revision (v3.5.3); this reflects a minor UI/backend update rather than changes to the trial information.SummaryDifference0.1%

- Check51 days agoChange DetectedA new Revision entry v3.5.3 has been added to the Record History, replacing the previous v3.5.2. This update reflects a change to the page's version history rather than to the study data or descriptions.SummaryDifference0.1%

- Check66 days agoChange DetectedRevision v3.5.2 has been added to the history. Revision v3.5.0 has been removed from the history.SummaryDifference0.1%

- Check94 days agoChange DetectedThe Record History includes a new revision entry v3.5.0 and removes the previous revision v3.4.3.SummaryDifference0.1%

Stay in the know with updates to ENABLE Study: Lanadelumab in HAE Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ENABLE Study: Lanadelumab in HAE Clinical Trial page.